X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8029) 8029
Book Chapter (211) 211
Newspaper Article (98) 98
Newsletter (84) 84
Magazine Article (64) 64
Book / eBook (49) 49
Web Resource (21) 21
Trade Publication Article (12) 12
Dissertation (9) 9
Conference Proceeding (2) 2
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
probiotics (6082) 6082
humans (3292) 3292
animals (3210) 3210
probiotics - pharmacology (2421) 2421
microbiology (2020) 2020
bacteria (1894) 1894
male (1441) 1441
microbiota (1359) 1359
pharmacology & pharmacy (1356) 1356
female (1343) 1343
probiotics - therapeutic use (1094) 1094
mice (1066) 1066
probiotic (1059) 1059
lactobacillus (1048) 1048
biotechnology & applied microbiology (989) 989
analysis (894) 894
lactic-acid bacteria (891) 891
probiotics - administration & dosage (847) 847
inflammation (818) 818
immunology (774) 774
prebiotics (769) 769
antibiotics (767) 767
research (748) 748
health aspects (732) 732
anti-bacterial agents - pharmacology (728) 728
intestine (713) 713
dietary supplements (681) 681
double-blind (670) 670
gut microbiota (648) 648
nutrition & dietetics (644) 644
rats (611) 611
nutrition (606) 606
in-vitro (603) 603
diet (598) 598
prevention (557) 557
strains (556) 556
fermentation (555) 555
microorganisms (551) 551
food science & technology (542) 542
medicine (538) 538
gastroenterology & hepatology (537) 537
research article (530) 530
feces - microbiology (505) 505
bifidobacterium (493) 493
intestines - microbiology (483) 483
studies (476) 476
adult (471) 471
cytokines (470) 470
metabolism (462) 462
diarrhea (450) 450
supplementation (440) 440
physiological aspects (435) 435
proteins (435) 435
food (427) 427
chemistry (414) 414
lactic acid bacteria (410) 410
gastrointestinal tract - microbiology (409) 409
yogurt (403) 403
infection (400) 400
immune system (398) 398
lactobacilli (394) 394
growth (391) 391
gene expression (387) 387
disease (383) 383
rodents (382) 382
applied microbiology (374) 374
milk (373) 373
multidisciplinary sciences (370) 370
disease models, animal (366) 366
hydrogen-ion concentration (363) 363
care and treatment (356) 356
digestive system (355) 355
expression (352) 352
immune response (343) 343
inflammatory bowel disease (340) 340
intestinal microbiota (340) 340
infections (338) 338
escherichia-coli (336) 336
agriculture, dairy & animal science (334) 334
life sciences (330) 330
clinical trials (329) 329
middle aged (326) 326
lactobacillus - physiology (324) 324
microbial sensitivity tests (324) 324
medicine, research & experimental (323) 323
biochemistry & molecular biology (320) 320
children (320) 320
pathogens (315) 315
probiotic bacteria (314) 314
survival (313) 313
infectious diseases (311) 311
pharmacology (310) 310
veterinary sciences (305) 305
chemistry/food science, general (303) 303
identification (301) 301
protein science (299) 299
science (298) 298
oxidative stress (295) 295
food and beverages (294) 294
antioxidants (292) 292
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8446) 8446
Russian (102) 102
Japanese (72) 72
Portuguese (53) 53
Spanish (31) 31
Chinese (30) 30
French (22) 22
Ukrainian (14) 14
Polish (12) 12
German (8) 8
Dutch (6) 6
Slovak (5) 5
Czech (4) 4
Korean (4) 4
Italian (3) 3
Hungarian (2) 2
Norwegian (2) 2
Serbian (2) 2
Slovenian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Corsican (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nutrients, ISSN 2072-6643, 2018, Volume 10, Issue 9, p. 1153
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltration of the liver, highly prevalent in the general population... 
Clinical trials | NAFLD | Dietary supplements | Nutraceuticals | VITAMIN-D | METAANALYSIS | HERBAL MEDICINE | PHYLLANTHUS-URINARIA | SUPPLEMENTATION | NUTRITION & DIETETICS | MILK THISTLE | LIFE-STYLE | nutraceuticals | dietary supplements | DOUBLE-BLIND | clinical trials | 1,25-DIHYDROXYVITAMIN D-3 | STEATOHEPATITIS | Probiotics - administration & dosage | Meta-Analysis as Topic | Resveratrol - pharmacology | Plant Extracts - pharmacology | Humans | Ubiquinone - analogs & derivatives | Curcumin - pharmacology | Non-alcoholic Fatty Liver Disease - therapy | Vitamin D - pharmacology | Fatty Acids, Unsaturated - pharmacology | Antioxidants - pharmacology | Randomized Controlled Trials as Topic | Ubiquinone - pharmacology | Berberine - pharmacology | Salvia miltiorrhiza - chemistry | Fatty Acids, Omega-3 - pharmacology | Obesity - therapy | Observational Studies as Topic | Xanthophylls - pharmacology | Silymarin - pharmacology | Dietary Supplements | Vitamin E - pharmacology | Polyunsaturated fatty acids | Liver | Anthropometry | Astaxanthin | Cardiovascular disease | Lipids | Optimization | Alcohol use | Fatty liver | Vitamin D | Coenzyme Q10 | Vitamin E | Hepatology | Resveratrol | Curcumin | Heart diseases | Functional foods & nutraceuticals | Obesity | Berberine | Liver diseases | Parameters | Diabetes mellitus | Metabolism | Hypothyroidism | Patients | Fatty acids | Herbal medicine | Probiotics | Cirrhosis | Weight control | Silymarin | Fibrosis | Insulin resistance | Adults | Infiltration | Diabetes | Hemodynamics | Tocopherol | Cardiovascular diseases
Journal Article
Trends in biotechnology (Regular ed.), ISSN 0167-7799, 2004, Volume 22, Issue 3, pp. 142 - 146
The main commercial use of biosurfactants is in pollution remediation because of their ability to stabilize emulsions. This enhances the solubility and... 
IN-VITRO | ITURIN-A | ANTIBIOTICS | ACTIVATION | BACILLUS-SUBTILIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ENHANCEMENT | MANNOSYLERYTHRITOL LIPIDS | BIOSURFACTANTS | GENE TRANSFECTION | PLASMINOGEN | Fibrinolysis - drug effects | Surface-Active Agents - therapeutic use | Antibiotics, Antineoplastic - pharmacology | Gram-Positive Bacteria - drug effects | Anti-Infective Agents - pharmacology | Humans | Peptides, Cyclic - pharmacology | Peptides, Cyclic - chemistry | Antifungal Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Anti-Infective Agents - chemistry | Fibrinolytic Agents - therapeutic use | Glycolipids - chemistry | Bacterial Adhesion - drug effects | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Peptides - chemistry | Antiviral Agents - therapeutic use | Glycolipids - pharmacology | Anti-Infective Agents - therapeutic use | Peptides - pharmacology | Surface-Active Agents - pharmacology | Fibrinolytic Agents - pharmacology | Antibiotics, Antineoplastic - therapeutic use | Cell Differentiation - drug effects | Lipoproteins - pharmacology | Peptides, Cyclic - therapeutic use | Anti-Bacterial Agents - pharmacology | Surface-Active Agents - chemistry | Lipopeptides | Peptides - therapeutic use | Salmonella | Signal transduction | Probiotics | E coli | Herpes viruses | Antimicrobial agents | Lipids | Genetic engineering | Drug resistance | Surfactants | Bacteriology
Journal Article
Clinical nutrition (Edinburgh, Scotland), ISSN 0261-5614, 2015, Volume 34, Issue 6, pp. 1080 - 1087
Journal Article
Journal of hepatology, ISSN 0168-8278, 2012, Volume 57, Issue 4, pp. 803 - 812
Background & Aims Due to its anatomic connection, the liver is constantly exposed to gut-derived bacterial products or metabolites. Disruption of gut... 
Gastroenterology and Hepatology | Probiotics | Hepatocellular carcinoma | Gut homeostasis | Endotoxin | CHRONIC LIVER-DISEASE | INTESTINAL FLORA | BARRIER FUNCTION | IL-6 PRODUCTION | HUMAN FECES | BACTERIAL TRANSLOCATION | REAL-TIME PCR | GROUP-SPECIFIC PRIMERS | GASTROENTEROLOGY & HEPATOLOGY | PREDOMINANT BACTERIA | Diethylnitrosamine - pharmacology | Diethylnitrosamine - toxicity | Endotoxins - blood | Alkylating Agents - pharmacology | Humans | Liver Neoplasms, Experimental - chemically induced | Male | Gastroenteritis - drug therapy | Lactobacillus - drug effects | HMGB1 Protein - metabolism | Carcinoma, Hepatocellular - etiology | Carcinoma, Hepatocellular - blood | Homeostasis - drug effects | Liver Neoplasms, Experimental - microbiology | Liver Neoplasms, Experimental - pathology | Penicillins - pharmacology | Dextran Sulfate - pharmacology | Endotoxins - metabolism | Liver Cirrhosis - complications | Gastrointestinal Tract - physiopathology | Gastrointestinal Tract - microbiology | Rats | Liver Cirrhosis - blood | Probiotics - pharmacology | Rats, Sprague-Dawley | Disease Progression | Bifidobacterium - drug effects | Animals | Carcinoma, Hepatocellular - pathology | Gastroenteritis - chemically induced | Gastroenteritis - metabolism | Probiotics - therapeutic use | Anti-Bacterial Agents - pharmacology | Enterococcus - drug effects | Cytokines - biosynthesis | Dextran | Liver cancer | International cooperation | Chromosomal proteins | Metabolites | Genes | Homeostasis | Transplantation of organs, tissues, etc | Sulfates
Journal Article
Nature medicine, ISSN 1546-170X, 2006, Volume 13, Issue 1, pp. 35 - 37
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that... 
MEDICINE, RESEARCH & EXPERIMENTAL | VISCERAL PAIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | NCFM | RATS | COLON INFLAMMATION | EXPRESSION | IRRITABLE-BOWEL-SYNDROME | HYPERSENSITIVITY | CELL BIOLOGY | Intestines - drug effects | Probiotics - administration & dosage | Abdominal Pain - prevention & control | Narcotic Antagonists - administration & dosage | Receptor, Cannabinoid, CB2 - physiology | Cannabinoid Receptor Antagonists | Humans | Colon - drug effects | Receptors, Cannabinoid - physiology | Analgesics, Opioid - pharmacology | Male | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Receptor, Cannabinoid, CB2 - biosynthesis | Indoles - administration & dosage | Receptors, Opioid, mu - biosynthesis | Dose-Response Relationship, Drug | Receptors, Opioid - physiology | Rectum - drug effects | Colon - physiopathology | Indoles - pharmacology | Receptors, Cannabinoid - biosynthesis | Rectum - microbiology | Morphine - pharmacology | Administration, Oral | Lactobacillus acidophilus - physiology | Abdominal Pain - physiopathology | Rats | Probiotics - pharmacology | Receptors, Opioid, mu - antagonists & inhibitors | Rats, Sprague-Dawley | HT29 Cells | Animals | Intestines - microbiology | Rectum - physiopathology | Analgesics, Opioid - administration & dosage | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Receptors, Opioid - biosynthesis | Colon - microbiology | Mice | Mice, Inbred BALB C | Intestines - physiopathology | Naloxone - administration & dosage | Morphine - administration & dosage | Receptors, Opioid, mu - physiology | Bacteria | Pain | Microbiology | Gastrointestinal diseases | Irritable bowel syndrome | Life Sciences
Journal Article
Journal Article
Journal Article
Poultry science, ISSN 0032-5791, 2014, Volume 93, Issue 2, pp. 389 - 399
Journal Article
Nature (London), ISSN 1476-4687, 2011, Volume 472, Issue 7341, pp. 57 - 63
Metabolomics studies hold promise for the discovery of pathways linked to disease processes. Cardiovascular disease (CVD) represents the leading cause of death... 
CHLAMYDIA-PNEUMONIAE | TRIMETHYLAMINE-N-OXIDE | DNA METHYLATION | MULTIDISCIPLINARY SCIENCES | MURINE MACROPHAGES | MOUSE | GENE-EXPRESSION | ATHEROSCLEROSIS | MICE | CORONARY-HEART-DISEASE | MASS-SPECTROMETRY | Choline - metabolism | Dietary Fats - metabolism | Metabolomics | Liver - enzymology | Diet - adverse effects | Atherosclerosis - genetics | Betaine - metabolism | Humans | Phosphatidylcholines - administration & dosage | Phosphatidylcholines - metabolism | Choline - blood | Dietary Fats - pharmacology | Oxygenases - metabolism | Cardiovascular Diseases - blood | Female | Atherosclerosis - microbiology | Betaine - blood | Methylamines - pharmacology | Cardiovascular Diseases - diagnosis | Methylamines - metabolism | Receptors, Scavenger - metabolism | Biomarkers - metabolism | Phosphatidylcholines - blood | Cardiovascular Diseases - metabolism | Risk Assessment | Atherosclerosis - chemically induced | Mice, Inbred C57BL | Phosphatidylcholines - pharmacology | Gene Expression Regulation | Methylamines - blood | Gastrointestinal Tract - microbiology | Biomarkers - blood | Dietary Fats - blood | Atherosclerosis - metabolism | Gastrointestinal Tract - metabolism | Cardiovascular Diseases - microbiology | Macrophages - metabolism | Phenotype | Animals | Choline - administration & dosage | Choline - pharmacology | Germ-Free Life | Cholesterol, HDL - blood | Mice | Oxygenases - genetics | Lecithin | Microbiota (Symbiotic organisms) | Physiological aspects | Research | Cardiovascular diseases | Metabolism | Health aspects | Risk factors | Plasma | Nuclear magnetic resonance--NMR | Heart attacks | Pathogenesis | Lipids | Cardiovascular disease | Probiotics | Metabolites | Diet | Atherosclerosis | Bacteria | Insulin resistance | Mass spectrometry | atherosclerosis | intestinal microbiota | choline | die